GSK Investigational Site

Tinténiac 35190

0 studies enrolling now · 2 studies all time

What they study most

Alzheimer's Disease

Studies at this site

• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease — Completed
• Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers — Stopped early